Jörg Bentzien is a Research Fellow in the Modeling and Informatics group at Alkermes, where he is leading the chemistry efforts on an early drug discovery project and providing modeling support throughout the drug discovery organization. Before joining Alkermes Jörg Bentzien worked at Forma Therapeutics, Watertown MA, Boehringer Ingelheim, Ridgefield CT, and Xencor, Monrovia CA. Dr. Bentzien has broad experience in drug discovery working on multiple targets in different disease areas, CNS, Immunology & Inflammation, Cardiometabolic diseases. While at Boehringer Ingelheim he implemented a suite of predictive ADMET models used throughout the Medicinal Chemistry department and pushed for automatically self-updating models. Jörg Bentzien has a Ph.D. in chemistry from the University of Münster, Germany and did post-doctoral studies with Nobel Laureate Arieh Warshel at the University of Southern California.